These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 24250942)

  • 1. Co-precipitation with PVP and Agar to Improve Physicomechanical Properties of Ibuprofen.
    Maghsoodi M; Kiafar F
    Iran J Basic Med Sci; 2013 Apr; 16(4):635-42. PubMed ID: 24250942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-precipitation with PVP and Agar to Improve Physicomechanical Properties of Ibuprofen.
    Maghsoodi M; Kiafar F
    Iran J Basic Med Sci; 2013 Apr; 16(4):602-9. PubMed ID: 24250936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ibuprofen crystals with optimized properties.
    Rasenack N; Müller BW
    Int J Pharm; 2002 Oct; 245(1-2):9-24. PubMed ID: 12270238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physico-mechanical and dissolution behaviours of ibuprofen crystals crystallized in the presence of various additives.
    Nokhodchi A; Amire O; Jelvehgari M
    Daru; 2010; 18(2):74-83. PubMed ID: 22615598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Preparation of ibuprofen/EC-PVP sustained-release composite particles by supercritical CO2 anti-solvent technology].
    Cai JY; Huang DC; Wang ZX; Dang BL; Wang QL; Su XG
    Yao Xue Xue Bao; 2012 Jun; 47(6):791-6. PubMed ID: 22919729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antisolvent precipitation technique: A very promising approach to crystallize curcumin in presence of polyvinyl pyrrolidon for solubility and dissolution enhancement.
    Sadeghi F; Ashofteh M; Homayouni A; Abbaspour M; Nokhodchi A; Garekani HA
    Colloids Surf B Biointerfaces; 2016 Nov; 147():258-264. PubMed ID: 27518458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation studies on ibuprofen sodium-cationic dextran conjugate: effect on tableting and dissolution characteristics of ibuprofen.
    Abioye AO; Kola-Mustapha A
    Drug Dev Ind Pharm; 2016 Jan; 42(1):39-59. PubMed ID: 25826253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation, characterization and in vivo evaluation of pharmacological activity of different crystal forms of ibuprofen.
    Li Y; Yao F; Shang C; Ren F; Zhang J; Li Y; Yang G; Lin R; Wang W
    Pak J Pharm Sci; 2019 Sep; 32(5):2139-2147. PubMed ID: 31813880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing various techniques to produce micro/nanoparticles for enhancing the dissolution of celecoxib containing PVP.
    Homayouni A; Sadeghi F; Varshosaz J; Garekani HA; Nokhodchi A
    Eur J Pharm Biopharm; 2014 Sep; 88(1):261-74. PubMed ID: 24952357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal habit modifications of ibuprofen and their physicomechanical characteristics.
    Garekani HA; Sadeghi F; Badiee A; Mostafa SA; Rajabi-Siahboomi AR
    Drug Dev Ind Pharm; 2001 Sep; 27(8):803-9. PubMed ID: 11699831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Properties of ibuprofen crystallized under various conditions: a comparative study.
    Rasenack N; Müller BW
    Drug Dev Ind Pharm; 2002 Oct; 28(9):1077-89. PubMed ID: 12455467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of solid state characteristics of spray-congealed Ibuprofen solid lipid microparticles and their impact on sustaining drug release.
    Wong PC; Heng PW; Chan LW
    Mol Pharm; 2015 May; 12(5):1592-604. PubMed ID: 25849584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highly compressible paracetamol: I: crystallization and characterization.
    Garekani HA; Ford JL; Rubinstein MH; Rajabi-Siahboomi AR
    Int J Pharm; 2000 Nov; 208(1-2):87-99. PubMed ID: 11064214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disorder and dissolution enhancement: deposition of ibuprofen on to insoluble polymers.
    Williams AC; Timmins P; Lu M; Forbes RT
    Eur J Pharm Sci; 2005 Nov; 26(3-4):288-94. PubMed ID: 16087323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solvent change co-precipitation with hydroxypropyl methylcellulose phthalate to improve dissolution characteristics of a poorly water-soluble drug.
    Sertsou G; Butler J; Hempenstall J; Rades T
    J Pharm Pharmacol; 2002 Aug; 54(8):1041-7. PubMed ID: 12195817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insight into Flufenamic Acid Cocrystal Dissolution in the Presence of a Polymer in Solution: from Single Crystal to Powder Dissolution.
    Guo M; Wang K; Qiao N; Fábián L; Sadiq G; Li M
    Mol Pharm; 2017 Dec; 14(12):4583-4596. PubMed ID: 29091446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-polymer miscibility, interactions, and precipitation inhibition studies for the development of amorphous solid dispersions for the poorly soluble anticancer drug flutamide.
    Trivino A; Gumireddy A; Meng F; Prasad D; Chauhan H
    Drug Dev Ind Pharm; 2019 Aug; 45(8):1277-1291. PubMed ID: 31111732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous micronization and surface modification for improvement of flow and dissolution of drug particles.
    Han X; Ghoroi C; To D; Chen Y; Davé R
    Int J Pharm; 2011 Aug; 415(1-2):185-95. PubMed ID: 21664954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal modification of phenytoin using different solvents and crystallization conditions.
    Nokhodchi A; Bolourtchian N; Dinarvand R
    Int J Pharm; 2003 Jan; 250(1):85-97. PubMed ID: 12480275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mathematical model to analyze the dissolution behavior of metastable crystals or amorphous drug accompanied with a solid-liquid interface reaction.
    Hirai D; Iwao Y; Kimura SI; Noguchi S; Itai S
    Int J Pharm; 2017 Apr; 522(1-2):58-65. PubMed ID: 28235625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.